VentriPoint Diagnostics (5V7) Financial Statements
VentriPoint Diagnostics Financial Overview
VentriPoint Diagnostics's market cap is currently $9.85M. The company's EPS TTM is $-0.01; its P/E ratio is -6.13; VentriPoint Diagnostics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 179.93K | $ 95.17K | $ 49.18K | $ 68.17K | $ 0.00 |
| Gross Profit | $ 118.69K | $ 95.17K | $ 42.43K | $ 57.81K | $ -48.81K |
| Operating Income | $ -3.40M | $ -4.80M | $ -4.93M | $ -4.91M | $ -3.72M |
| EBITDA | $ -2.67M | $ -4.76M | $ -4.74M | $ -4.79M | $ -3.81M |
| Net Income | $ -3.20M | $ -4.92M | $ -4.87M | $ -4.87M | $ -3.88M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 55.39K | $ 60.55K | $ 1.29M | $ 5.19M | $ 9.27M |
| Total Assets | $ 472.08K | $ 658.02K | $ 1.88M | $ 5.98M | $ 9.54M |
| Total Debt | $ 2.60M | $ 1.63M | $ 412.44K | $ 459.08K | $ 159.97K |
| Net Debt | $ 2.55M | $ 1.57M | $ -881.91K | $ -4.73M | $ -9.11M |
| Total Liabilities | $ 4.59M | $ 3.64M | $ 1.69M | $ 1.42M | $ 1.21M |
| Stockholders' Equity | $ -4.12M | $ -2.98M | $ 189.71K | $ 4.55M | $ 8.33M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.55M | $ -3.39M | $ -3.80M | $ -4.14M | $ -3.15M |
| Operating Cash Flow | $ -1.55M | $ -3.39M | $ -3.80M | $ -4.14M | $ -3.15M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -4.26K |
| Financing Cash Flow | $ 1.53M | $ 2.20M | $ -102.36K | $ 87.65K | $ 11.89M |
Currency in CAD